Status:
COMPLETED
Impact of Intra-Shift Napping on EMS Cardiovascular Health
Lead Sponsor:
University of Pittsburgh
Collaborating Sponsors:
ZOLL Foundation
Conditions:
Blood Pressure
Heart Rate Variability
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
Cardiovascular disease (CVD) exerts a significant health burden among shift workers, including police, firefighters, and emergency medical services (EMS). The unique occupational demands inherent to t...
Detailed Description
Cardiovascular disease (CVD) exerts a significant health burden among shift workers, including police, firefighters, and emergency medical services (EMS). The unique occupational demands inherent to t...
Eligibility Criteria
Inclusion
- age 18 years or older;
- current / active certification as an EMS clinician at the EMT-Basic, Advanced, Paramedic, Flight Paramedic, or Flight Nurse level, or healthcare shift worker;
- has not ever been diagnosed with any of the following: hypertension, cardiovascular disease, myocardial infarction, stroke/TIA, chronic kidney disease, adrenal disease, thyroid disease, rheumatologic disease, hematologic disease, cancer of any type, dementia/memory loss, organ transplantation; insomnia or other major sleep problem; sleep apnea or other diagnosis that is related to problems with breathing or the airway; and
- is not currently pregnant.
Exclusion
- 17 years of age or younger;
- not an EMS clinician or inactive as an EMS clinician or not a healthcare shift worker;
- has ever been diagnosed with hypertension, cardiovascular disease, myocardial infarction, stroke/TIA, chronic kidney disease, adrenal disease, thyroid disease, rheumatologic disease, hematologic disease, cancer of any type, dementia/memory loss, organ transplantation; insomnia or other major sleep problem; sleep apnea or other diagnosis that is related to problems with breathing or the airway;
- is currently pregnant;
- is unwilling to wear multiple monitoring devices (e.g., automated blood pressure monitoring device, holter monitor for HRV measurement, wrist actigraphy) for the duration of the study protocol.
- is unwilling to refrain from caffeine during the study protocol; or
- is unwilling to adhere to sleep / wake times outlined in the study protocol.
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 2 2022
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT04469803
Start Date
March 1 2021
End Date
October 2 2022
Last Update
May 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15261